Browsing by Author "Koyuncu, IV"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-air®Bousquet, J; Sousa-Pinto, B; Anto, JM; Bedbrook, A; Czarlewski, W; Ansotegui, IJ; Bergmann, KC; Braido, F; Brussino, L; Cecchi, L; Loureiro, CC; Cruz, AA; Devillier, P; Fiocchi, A; Gemicioglu, B; Haahtela, T; Ivancevich, JC; Klimek, L; Kulus, M; Kuna, P; Kupczyk, M; Kvedariene, V; Larenas-Linnemann, DE; Louis, G; Louis, R; Makris, M; Morais-Almeida, M; Niedoszytko, M; Ohta, K; Ollert, M; Papadopoulos, N; Patella, V; Pétré, B; Pfaar, O; Puggioni, F; Quirce, S; Regateiro, FS; Roche, N; Rouadi, PW; Samolinski, B; Sastre, J; Schleich, F; Scichilone, N; Taborda-Barata, L; Toppila-Salmi, S; Valiulis, A; Koyuncu, IV; Ventura, MT; Yorgancioglu, A; Fonseca, JA; Zuberbier, TPatient-reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person-centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK-air (R) (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut-offs and responsiveness. Then, a multicentric, multinational, double-blind, placebo-controlled, randomised control trial (DB-PC-RCT) using an electronic VAS form was carried out. Finally, with the development of MASK-air (R) in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness.